09:39 EST Corbus Pharmaceuticals trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRBP:
- CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encouraging Safety and Efficacy in Patients with Nectin-4 Positive Tumors in First-In-Human Study Presented at ASCO-GU 2024
- Corbus Pharmaceuticals to present Phase 1 clinical data for SYS6002
- Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antibody (CRB-601)
- Corbus Pharmaceuticals announces FDA clearance of IND application of CRB-601
- Corbus Pharmaceuticals announces abstract accepted for presentation